Semaphorin 7A (Sema7A, designated CD108, previously Sema K1 or Sema L), is an ~80 kDa membrane-anchored glycoprotein that is a member of the Semaphorin family of axon guidance molecules (1-4). On human erythrocytes, it is the John Milton Hagen (JMH) blood group antigen (4). Sema7A is the only known Class 7 or glycophosphatidylinositol (GPI)-linked semaphorin; its expression is concentrated in the brain, spleen and thymus (1-5). Human Sema7A cDNA encodes a 44 amino acid (aa) signal sequence, a 604 aa extracellular domain (ECD) including Sema and C2-type Ig-like domains, and an 18 aa propeptide/GPI membrane anchor signal sequence. Mature human Sema7A shares 89%, 89%, 88%, 86% and 90% aa identity with mouse, rat, canine, bovine and equine Sema7A, respectively. The Sema7A sema domain contains an RGD integrin interaction motif (4). Although it binds plexin-C1
in vitro and may be coexpressed with it, many of its activities depend on interaction with beta 1 integrins such as alpha 1 beta 1 (6-10). Sema7A signaling through the two receptors may cause opposing effects (8). Sema7A is an immune semaphorin, with expression and activity on CD4
+CD8
+ thymocytes, activated T cells, macrophages and microglia (2, 9-12). T cell-expressed Sema7A interacts with monocytic cells, stimulating their chemotaxis, production of pro-inflammatory cytokines, and dendritic differentiation (5, 6). However, on the T cells themselves, Sema7A downregulates TCR signaling by promoting TCR internalization, modulating T cell responses (9). In lung macrophages, Sema7A is induced by TGF-beta and participates in TGF-beta -induced lung fibrosis (12). Sema7A is also expressed on pre-osteoblasts and osteoclasts, where it promotes migration and fusion, respectively; on keratinocytes, where it promotes melanocyte spreading and dendricity; and on some neurons, for example, promoting axon outgrowth in the developing olfactory tract (8, 10, 13).
- Yazdani, U. and J.R. Terman (2006) Genome Biol. 7:211.
- Kikutani, H. et al. (2007) Adv. Immunol. 93:121.
- Sato, Y. and Takahashi H. (1998) Biochim. Biophys. Acta. 1443:419.
- Yamada, A. et al. (1999) J. Immunol. 162:4094.
- Holmes, S. et al. (2002) Scand. J. Immunol. 56:270.
- Suzuki, K. et al. (2007) Nature 446:680.
- Pasterkamp, R.J. et al. (2007) BMC Dev. Biol. 7:98.
- Scott, G.A. et al. (2007) J. Invest. Dermatol. 128:151.
- Czopik, A.K. et al. (2006) Immunity 24:591.
- Pasterkamp, R.J. et al. (2003) Nature 424:398.
- Mine, T. et al. (2000) Tissue Antigens 55:429.
- Kang, H.R. et al. (2007) J. Exp. Med. 204:1083.
- Delorme, G. et al. (2005) Biol. Cell 97:589.